Liberty Drug Recalls Hydroxocobalamin Injectable Due to Sterility Concerns
Liberty Drug & Surgical is recalling 15 vials of Hydroxocobalamin Injectable due to process deficiencies that could have compromised sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable product, which aligns with the rubric criteria for Severe severity due to the potential for significant injury from non-sterile administration.
Plain-English summary
Liberty Drug & Surgical is recalling 15 vials of Hydroxocobalamin (Preserved) 10,000 mcg/mL Injectable, 1 mL vial, Rx only. The affected product is identified by Lot # 06082015@5 and has an expiration date of 07/24/15.
The recall was initiated because process deficiencies were observed in the sterile ophthalmic and injectable products, which could have compromised the sterility of the product. This lack of assurance of sterility poses a potential risk to patients.
The product was distributed to physicians, medical facilities, and prescription-specific patients in New Jersey and New York. Patients and healthcare providers should stop using the affected vials and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Hydroxocobalamin (Preserved) 10,000 mcg/mL Injectable, 1 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ 07928.
- Manufacturer
- Liberty Drug & Surgical
- Category
- Drug — Injectable
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 06082015@5
- Exp 07/24/15
Distribution
Part of a larger recall action
This product is one of 25 recalled by Liberty Drug & Surgical under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Liberty Drug & Surgical
See all →- SevereLiberty Drug Recalls Papaverine Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Doxycycline IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Dexamethasone Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls Doxycycline IV Bags Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SevereLiberty Drug Recalls 17-Hydroxyprogesterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
Same hazard · sterility compromise
See all →- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighMedline Recalls Cataract Convenience Kits Due to Open Sterile Seals
FDA (Devices) · 2026-09-23
- HighMedline Myringotomy Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMedline Anesthesia Pain Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMaquet Percutaneous Insertion Kit Recalled for Sterile Barrier Integrity Issues
FDA (Devices) · 2026-09-23
Similar recalls
- SevereHydroxocobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- SevereRXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- HighHydroxocobalamin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-07-20
- SevereFDA Recalls Hydroxocobalamin Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereBedford Pharmacy Recalls Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-10-21
- SevereFDA Recalls Hydroxocobalamin Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12